|14.39 0.1 (0.7%)||12-06 16:00|
|Targets||6-month :||17.43||1-year :||20.36|
|Resists||First :||14.93||Second :||17.43|
|Supports||First :||12.56||Second :||11.1|
|MAs||MA(5) :||14.29||MA(20) :||13.76|
|MA(100) :||13.24||MA(250) :||14.66|
|MACD||MACD :||0.4||Signal :||0.4|
|%K %D||K(14,3) :||78.1||D(3) :||81.1|
|52-week||High :||19.09||Low :||9.93|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HLVX ] has closed below upper band by 18.3%. Bollinger Bands are 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||14.95 - 15.01||15.01 - 15.06|
|Low:||14.09 - 14.17||14.17 - 14.23|
|Close:||14.27 - 14.38||14.38 - 14.48|
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Fri, 24 Nov 2023
Have Insiders Sold HilleVax Shares Recently? - Simply Wall St
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
|Shares Out||48 (M)|
|Shares Float||20 (M)|
|Held by Insiders||8.9 (%)|
|Held by Institutions||72.6 (%)|
|Shares Short||495 (K)|
|Shares Short P.Month||535 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||6.55|
|Profit Margin||0 %|
|Operating Margin||0 %|
|Return on Assets (ttm)||-21.1 %|
|Return on Equity (ttm)||-36.8 %|
|Qtrly Rev. Growth||0 %|
|Gross Profit (p.s.)||0|
|Sales Per Share||0|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||-84 (M)|
|Levered Free Cash Flow||-68 (M)|
|Price to Book value||2.19|
|Price to Sales||0|
|Price to Cash Flow||-8.33|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|